Stanzick KJ, Li Y, Schlosser P, Gorski M, Wuttke M, Thomas LF, et al. Discovery and prioritization of variants and genes for kidney function in > 1.2 million individuals. Nat Commun. 2021;12(1):4350.
Article CAS PubMed PubMed Central Google Scholar
Hariparshad S, Bhimma R, Nandlal L, Jembere E, Naicker S, Assounga A. The prevalence of chronic kidney disease in South Africa-limitations of studies comparing prevalence with sub-saharan Africa, Africa, and globally. BMC Nephrol. 2023;24(1):62.
Article PubMed PubMed Central Google Scholar
De Bhailis ÁM, Kalra PA. Hypertension and the kidneys. Br J Hosp Med. 2022;83(5):1–11.
Zandi-Nejad K, Luyckx VA, Brenner BM. Adult hypertension and kidney disease: the role of fetal programming. Hypertension. 2006;47(3):502–8.
Article CAS PubMed Google Scholar
Gjerde A. Low birth weight, intrauterine growth restriction and risk of chronic kidney disease in adult age. 2022.
Xie D, Ma T, Cui H, Li J, Zhang A, Sheng Z, et al. Global burden and influencing factors of chronic kidney disease due to type 2 diabetes in adults aged 20–59 years, 1990–2019. Sci Rep. 2023;13(1):20234.
Article ADS PubMed PubMed Central Google Scholar
Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med. 2010;2(7):247–57.
Article CAS PubMed PubMed Central Google Scholar
Pollock DM. Renal endothelin in hypertension. Curr Opin Nephrol Hypertens. 2000;9(2):157–64.
Article CAS PubMed Google Scholar
Sasser JM, Pollock JS, Pollock DM. Renal endothelin in chronic angiotensin II hypertension. Am J Physiology-Regulatory Integr Comp Physiol. 2002;283(1):R243–R8.
Navar L, Inscho E, Majid S, Imig J, Harrison-Bernard L, Mitchell K. Paracrine regulation of the renal microcirculation. Physiol Rev. 1996;76(2):425–536.
Article CAS PubMed Google Scholar
Rüster C, Wolf G. Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol. 2006;17(11):2985–91.
Siragy HM, Carey RM. Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. Am J Nephrol. 2010;31(6):541–50.
Article CAS PubMed PubMed Central Google Scholar
Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension. 2004;44(5):595–601.
Article CAS PubMed Google Scholar
Shankland S. The podocyte’s response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 2006;69(12):2131–47.
Article CAS PubMed Google Scholar
Folkow B, Göthberg G, Lundin S, Ricksten SE. Structural resetting of the renal vascular bed in spontaneously hypertensive rats (SHR). Acta Physiol Scand. 1977;100(2):270–2.
Article CAS PubMed Google Scholar
Buffet L, Ricchetti C. Chronic kidney disease and hypertension: A destructive combination. 2012.
Heerspink HJL, Gansevoort RT. Albuminuria is an appropriate therapeutic target in patients with CKD: the pro view. Clin J Am Soc Nephrol. 2015;10(6):1079–88.
Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco AL, De Jong PE, et al. Kidney disease: improving global outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Supplements. 2013;3(1):1–150.
Lopez-Giacoman S, Madero M. Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol. 2015;4(1):57.
Article PubMed PubMed Central Google Scholar
Heerspink HJL, Gansevoort RT. Albuminuria is an appropriate therapeutic target in patients with CKD: the pro view. Clin J Am Soc Nephrology: CJASN. 2015;10(6):1079.
Good DM, Zürbig P, Argiles A, Bauer HW, Behrens G, Coon JJ, et al. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteom. 2010;9(11):2424–37.
Wu I-W, Tsai T-H, Lo C-J, Chou Y-J, Yeh C-H, Chan Y-H, et al. Discovering a trans-omics biomarker signature that predisposes high risk diabetic patients to diabetic kidney disease. Npj Digit Med. 2022;5(1):166.
Article PubMed PubMed Central Google Scholar
Cisek K, Krochmal M, Klein J, Mischak H. The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease. Nephrol Dialysis Transplantation. 2016;31(12):2003–11.
Provenzano M, Serra R, Garofalo C, Michael A, Crugliano G, Battaglia Y, et al. Omics in chronic kidney disease: focus on prognosis and prediction. Int J Mol Sci. 2021;23(1):336.
Article PubMed PubMed Central Google Scholar
Mischak H, Delles C, Klein J, Schanstra JP. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application. Adv Chronic Kidney Dis. 2010;17(6):493–506.
Fan G, Gong T, Lin Y, Wang J, Sun L, Wei H, et al. Urine proteomics identifies biomarkers for diabetic kidney disease at different stages. Clin Proteomics. 2021;18(1):1–12.
Pontillo C, Mischak H. Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease. Clin Kidney J. 2017;10(2):192–201.
Article CAS PubMed PubMed Central Google Scholar
De Beer D, Mels CM, Schutte AE, Delles C, Mary S, Mullen W, et al. Identifying a urinary peptidomics profile for hypertension in young adults: the African-PREDICT study: urinary peptidomics and hypertension. Proteomics. 2023;23(11):2200444.
Kalyesubula R, Fabian J, Nakanga W, Newton R, Ssebunnya B, Prynn J, et al. How to estimate glomerular filtration rate in sub-saharan Africa: design and methods of the African Research into kidney diseases (ARK) study. BMC Nephrol. 2020;21(1):1–12.
Craik A, Gondwe M, Mayindi N, Chipungu S, Khoza B, Gómez-Olivé X, et al. Forgotten but not gone in rural South Africa: urinary schistosomiasis and implications for chronic kidney disease screening in endemic countries. Wellcome Open Res. 2023;8(68):68.
Article PubMed PubMed Central Google Scholar
George JA, Brandenburg J-T, Fabian J, Crowther NJ, Agongo G, Alberts M, et al. Kidney damage and associated risk factors in rural and urban sub-saharan Africa (AWI-Gen): a cross-sectional population study. Lancet Global Health. 2019;7(12):e1632–e43.
Nweke EE, Naicker P, Aron S, Stoychev S, Devar J, Tabb DL, et al. SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular pathways. PLoS ONE. 2020;15(10):e0240453.
Article CAS PubMed PubMed Central Google Scholar
Govender IS, Mokoena R, Stoychev S, Naicker P. Urine-HILIC: automated sample preparation for bottom-up urinary proteome profiling in clinical proteomics. Proteomes. 2023;11(4):29.
Article CAS PubMed PubMed Central Google Scholar
Röst HL, Rosenberger G, Navarro P, Gillet L, Miladinović SM, Schubert OT, et al. OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data. Nat Biotechnol. 2014;32(3):219–23.
Reiter L, Rinner O, Picotti P, Hüttenhain R, Beck M, Brusniak M-Y, et al. mProphet: automated data processing and statistical validation for large-scale SRM experiments. Nat Methods. 2011;8(5):430–5.
Article CAS PubMed Google Scholar
Zhang B, Chambers MC, Tabb DL. Proteomic parsimony through bipartite graph analysis improves accuracy and transparency. J Proteome Res. 2007;6(9):3549–57.
Article CAS PubMed PubMed Central Google Scholar
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504.
Article CAS PubMed PubMed Central Google Scholar
Torun FM, Virreira Winter S, Doll S, Riese FM, Vorobyev A, Mueller-Reif JB, et al. Transparent exploration of machine learning for biomarker discovery from proteomics and omics data. J Proteome Res. 2022;22(2):359–67.
Article PubMed PubMed Central Google Scholar
Benson LN, Guo Y, Deck K, Mora C, Liu Y, Mu S. The link between immunity and hypertension in the kidney and heart. Front Cardiovasc Med. 2023;10.
Mattson DL. Infiltrating immune cells in the kidney in salt-sensitive hypertension and renal injury. Am J Physiology-Renal Physiol. 2014;307(5):F499–F508.
留言 (0)